| Date Filed | Type | Description |
| 08/08/2023 |
8-K
| Quarterly results |
| 06/29/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/30/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/08/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/23/2023 |
8-K
| Quarterly results |
| 01/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/05/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/08/2022 |
8-K
| Quarterly results |
| 11/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/20/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
8-K
| Quarterly results |
| 08/09/2022 |
8-K
| Quarterly results |
| 07/21/2022 |
8-K
| Quarterly results |
| 07/18/2022 |
8-K/A
| Quarterly results |
| 06/03/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 05/06/2022 |
8-K
| Quarterly results |
| 04/27/2022 |
8-K
| Quarterly results |
| 04/25/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/14/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Separation Agreement, by and between NeoGenomics, Inc. and Mark Mallon",
"NeoGenomics Announces CEO Departure and Initiates CEO Search Board Appoints Executive Chair and Interim Office of the CEO Anticipates First Quarter Results Below Guidance and Withdraws 2022 Guidance Ft. Myers, Florida—March 28, 2022 / NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that the Board of Directors and Mark Mallon, Chief Executive Officer, have agreed that Mr. Mallon will step down as CEO and member of the Board, effective immediately. This mutual agreement was not the result of any disagreements about strategy with management or the Board, inappropriate action by CEO, or any violation of company policy or any accounting irregularity. The Board has retained Russell Reynolds to condu..." |
|
| 03/09/2022 |
8-K
| Quarterly results |
| 02/23/2022 |
8-K
| Quarterly results |
| 01/19/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/10/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/04/2021 |
8-K
| Quarterly results |
| 10/12/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/01/2021 |
8-K/A
| Quarterly results |
| 08/10/2021 |
8-K
| Quarterly results |
| 08/06/2021 |
8-K
| Quarterly results |
|